Posts

Wave Life Sciences Obesity Biomarker Data Raise Hopes for Future Readouts

on

Altanine Strengthens Scientific Advisory Board with Appointment of Dr. Bruce D. Forrest

on

Sirona Medical Receives FDA 510(k) Clearance for Advanced Imaging Suite, Expanding PET-CT and Class II Medical Device Functionality

on

Friday Five: Lilly Expands Zepbound’s DTC Reach, NVIDIA Powers Drug Discovery at Lilly and Verily, and OpenAI Advances Pharma AI Initiatives

on

WuXi AppTec Divests China Clinical Services to Hillhouse Capital, Refocuses on Manufacturing Business

on

Vistagen Appoints Paul Edick to its Board of Directors

on

RFK Jr. Reshuffles Top Leadership at HHS, Replaces Chief of Staff and Deputy Policy Chief

on

Astellas Pharma Revises Financial Forecasts for FY2025

on

WuXi AppTec Sells China-Based Clinical Research Units to Hillhouse Investment Management

on

AI-Designed Drug AH-001 Completes U.S. Phase I Trial, Demonstrating Excellent Safety and Tolerability

on

Viking Therapeutics to Highlight VK2735 Clinical Data at ObesityWeek 2025

on

Regeneron and ModeX Forge Potential $1 Billion+ Collaboration to Develop Multispecific Antibody Drugs

on

More Than a Third of New Zepbound Prescriptions Driven by Lilly’s DTC Program

on

Astellas Pharma Revises Financial Forecasts for FY2025

on

WuXi AppTec Sells China-Based Clinical Research Units to Hillhouse Investment Management

on

AI-Designed Drug AH-001 Completes U.S. Phase I Trial, Demonstrating Excellent Safety and Tolerability

on

Viking Therapeutics to Highlight VK2735 Clinical Data at ObesityWeek 2025

on

Regeneron and ModeX Forge Potential $1 Billion+ Collaboration to Develop Multispecific Antibody Drugs

on

More Than a Third of New Zepbound Prescriptions Driven by Lilly’s DTC Program

on

FDA Reduces Regulatory Red Tape for Biosimilars

on

Ventus Therapeutics Continues Phase 2a Trial of VENT-02 NLRP3 Inhibitor in Parkinson's Disease; No Indication of Program Halt

on

Roche Signs $1B Licensing Deal with Qyuns Therapeutics for Preclinical COPD Bispecific Antibody

on

Takeda Makes Pipeline Cuts and Faces Softer Q2 Sales Due to Generic Competition

on

Eli Lilly Blows Past Revenue Benchmarks, Again Raises Full-Year Outlook

on

Novo Nordisk Launches Surprise Bid for Metsera, Topping Pfizer Offer; Pfizer Alleges Move May Violate Antitrust Law

on

Cytek Biosciences Deepens Commitment to Expanding Access to Flow Cytometry

on

United Imaging Healthcare Q3 2025 Results: Overseas Revenue Up 42% YoY

on

Step Pharma Appoints Dr. Karen L. Smith as Chief Medical Officer

on

GSK Trims Pipeline and Upgrades Guidance in Emma Walmsley's Last Earnings Report

on

Jazz Pharmaceuticals Appoints Dr. Ted Love to Board of Directors

on

BioMarin Plans to Divest Hemophilia Gene Therapy Roctavian Amid Strategic Refocus

on

Eli Lilly and Nvidia to Build Pharma’s Largest AI Supercomputer for Drug Discovery

on

No Recent News on BridgeBio's Thyroid Disorder Phase 3 Win

on

Merck & Co.'s Welireg Notches Wins in Kidney Cancer Combo Studies

on

Cigna Announces End to Drug Rebates for Many Health Plans Beginning in 2027

on

Expert Insights to Navigate Your CGT Challenges: Recent Updates and Strategic Guidance for 2025

on

Intellia Pauses Two CRISPR Trials After Severe Liver Toxicity Hospitalizes Patient

on

Clearmind Medicine Appoints Mary-Elizabeth Gifford as Chief of Global Impact

on

OpenAI Collaborates with Thermo Fisher and Lundbeck to Enhance Pharma Research

on

Edison Oncology Presents Two Posters at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

on

Bayer Receives FDA Approval for Lynkuet, a Novel Non-Hormonal Drug for Menopausal Hot Flashes

on